Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Public ClinicalTrials.gov record NCT01409031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Study identification
- NCT ID
- NCT01409031
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Colorado, Denver
- Other
- Enrollment
- 3 participants
Conditions and interventions
Interventions
- Intravenous Sildenafil Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- Up to 72 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2011
- Primary completion
- Sep 30, 2013
- Completion
- Sep 30, 2013
- Last update posted
- Jan 31, 2019
2011 – 2013
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado Health Sciences Center | Aurora | Colorado | 80045 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Anne and Robert H Lurie Children's Hospital of Chicago | Chicago | Illinois | 60614 | — |
| Women's & Children's Hospital of Buffalo SUNY | Buffalo | New York | 14222 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| Primary Children's Medical Center, Utah | Salt Lake City | Utah | 84113 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01409031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01409031 live on ClinicalTrials.gov.